Wei Pei

This inventor holds 9 USPTO granted patents and 3 published patent applications and 5 EPO patents. Top assignees: Irm LLC, Novartis Ag, Other. Active years: 2010-2021.

USPTO Granted Patents = 9 (Patent Applications = 3)

% Patents Active = 66.7

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 6.1

ph-index = 5

Forward Citations = 83(Granted Patents)

Company Filing History:

1 out of 834,307

Other

patents

Years Active: 2010-2021

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10954233 - Compounds and compositions as inhibitors of endosomal toll-like receptors (2021-03-23),

2. 8957081 - Compounds and compositions as protein kinase inhibitors (2015-02-17),

3. 8592432 - Compounds and compositions as protein kinase inhibitors (2013-11-26),

4. 8518931 - Compounds and compositions as kinase inhibitors (2013-08-27),

5. 8399450 - Compounds and compositions as protein kinase inhibitors (2013-03-19),

6. 8377921 - Compounds and compositions as protein kinase inhibitors (2013-02-19),

7. 8372858 - Compounds and compositions as protein kinase inhibitors (2013-02-12),

8. 8039479 - Compounds and compositions as protein kinase inhibitors (2011-10-18),

9. 7807841 - Spiro-containing compounds and compositions as modulators of steroid hormone nuclear receptors (2010-10-05),

Of course! Here is an article about inventor Wei Pei:

Title: Innovator Spotlight: Wei Pei - Revolutionizing the Pharma Industry

Introduction:

Wei Pei, a brilliant inventor based in San Diego, CA, is making waves in the pharmaceutical industry with his groundbreaking patents and innovative research. With an impressive portfolio of 9 patents to his name, Wei Pei is a true trailblazer in the field of drug development.

Latest Patents:

Among his latest patents, Wei Pei has introduced compounds and compositions as inhibitors of endosomal toll-like receptors. These compounds have shown promising results in the treatment of autoimmune diseases. Additionally, his work on protein kinase inhibitors, including pyrimidine and pyridine derivatives, has opened up new possibilities for treating conditions that respond to the inhibition of specific enzymes.

Career Highlights:

Wei Pei's career is marked by his influential work at Irm LLC and other prestigious companies in the pharmaceutical sector. His dedication to innovation and scientific excellence has led to significant advancements in drug discovery and development. Wei Pei's contributions have not only enhanced the understanding of various diseases but have also paved the way for novel treatment options.

Collaborations:

Throughout his career, Wei Pei has collaborated with top-tier professionals in the industry, including Pierre-Yves Michellys and Thomas H Marsilje, III. These collaborations have fostered a culture of creativity and knowledge-sharing, resulting in multidisciplinary approaches to solving complex healthcare challenges.

Conclusion:

In conclusion, Wei Pei stands out as a visionary inventor who continues to push the boundaries of pharmaceutical research. His relentless pursuit of innovation and his commitment to improving patient outcomes make him a true pioneer in the field. With a bright future ahead, Wei Pei is set to revolutionize the pharma industry and make a lasting impact on healthcare worldwide.